Press release
Microbiome Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapies, ROA, MOA and Key Companies involved by DelveInsight | Ferring Pharmaceuticals, Miyarisan Pharmaceutical, Seres therapeutics, 4D Pharma, Caelus Health, MRM Health, Scioto Biosc
Microbiome Pipeline
Key Takeaways from the Microbiome Competitive Landscape Report
• DelveInsight's Microbiome report depicts a robust space with 130+ Microbiome companies working to develop 180+ pipeline therapies for Microbiome treatment.
• The leading Microbiome Companies working in the market include Ferring Pharmaceuticals, Miyarisan Pharmaceutical, Seres therapeutics, 4D Pharma, Caelus Health, MRM Health, Scioto Biosciences, Adiso Therapeutics, Servatus Biopharmaceuticals, Second Genome, Finch Research and Development LLC., MaaT Pharma, Qu Biologics, Da Volterra, Exeliom Biosciences, and others.
• Promising Microbiome Therapies in the various stages of development include Arabinogalactan, Maltodextrin, Omadacycline, Vancomycin Pill, Crisaborole 2% Top Oint, and others.
• December 2023: Viome Company- This is a longitudinal, observational study to understand vaginal microbiome changes both within a single day and across a menstrual cycle. The study will be composed of at least 10 women who have regular menstrual cycles and are 18 years of age or older. This study is direct to participants and will NOT utilize clinical sites.
• April 2023: ADM, a global leader in nutrition that powers many of the world's top food, beverage, and health and wellness brands, and Brightseed, the bioactives company and a World Economic Forum Global Innovator, announced a global joint partnership to develop evidence-based functional synbiotic products that target microbiome optimization with an undisclosed investment. ADM is leveraging Brightseed's artificial intelligence (A.I.) platform, Forager®, to decipher the molecular interactions between dietary plants and gut microbes, and their potential impact on human health.
• March 2023: Sequential Skin Inc. ("Sequential"), the skin microbiome company developing next-generation non-invasive skin testing and data-driven solutions for the skin microbiome, announced that it has entered into a collaboration agreement with Johnson & Johnson Consumer Inc. The collaboration will focus on developing new methods for non-invasive genomic-based skin testing, to help Sequential add to their growing database of skin samples.
Request a sample and discover the recent advances in Microbiome Drugs @ Microbiome Competitive Landscape Report- https://www.delveinsight.com/report-store/microbiome-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
The Microbiome Report provides in-depth commercial assessment of Microbiome drugs that have been included, which comprises collaboration, agreement, licensing and acquisition - deals values trends. The sub-segmentation is described in the report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.
Microbiome Overview
Microbiome refers to collection of microbes and their interaction with the human body. Microbiome plays an important role in human physiology and disease. The microbes and their interaction with the human body show the various aspects of human biology.
Find out more about Microbiome Analytical Perspective: In-depth Commercial Assessment @ Microbiome Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/microbiome-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Microbiome Companies and Therapies
• Seres Therapeutics: SER-109
• 4D Pharma: Blautix
• Scioto Biosciences Inc.: SB-121
• Seres Therapeutics: SER-302
Microbiome Competitive Landscape
The Microbiome report comprises of comparative assessment of Companies (by therapy, development stage, and technology).
Microbiome Report Assessment
• Microbiome Company Analysis
• Microbiome Therapeutic Assessment
• Microbiome Pipeline Assessment
• Microbiome Inactive Drugs Assessment
• Microbiome Unmet Needs
Learn more about the emerging Microbiome Competitive Landscape @ Microbiome Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/microbiome-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Microbiome Competitive Landscape Report
• Coverage- Global
• Microbiome Companies- Ferring Pharmaceuticals, Miyarisan Pharmaceutical, Seres therapeutics, 4D Pharma, Caelus Health, MRM Health, Scioto Biosciences, Adiso Therapeutics, Servatus Biopharmaceuticals, Second Genome, Finch Research and Development LLC., MaaT Pharma, Qu Biologics, Da Volterra, Exeliom Biosciences, and others.
• Microbiome Therapies- Arabinogalactan, Maltodextrin, Omadacycline, Vancomycin Pill, Crisaborole 2% Top Oint, and others.
• Microbiome Therapeutics Assessment- Product Type, Stage and Product Type, Route of Administration, Stage and Route of Administration, Molecule Type, Stage and Molecule Type
Dive deep into rich insights for new drugs for Microbiome Product Developmental Activities, Visit @ Microbiome Research and Development Activities- https://www.delveinsight.com/sample-request/microbiome-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Introduction
2. Executive Summary
3. Microbiome: Overview
4. Microbiome-Analytical Perspective: In-depth Commercial Assessment
5. Competitive Landscape
6. Therapeutic Assessment
7. Microbiome: Company and Product Profiles (Marketed Therapies)
8. Ferring pharmaceuticals
9. RBX 2660
10. Microbiome: Company and Product Profiles (Pipeline Therapies)
11. Late Stage Products (Registered)
12. Seres Therapeutics
13. SER-109
14. Drug profiles in the detailed report…..
15. Mid Stage Products (Phase II)
16. 4D Pharma
17. Blautix
18. Drug profiles in the detailed report…..
19. Early Stage Products (Phase I)
20. Seres Therapeutics
21. SER-301
22. Drug profiles in the detailed report…..
23. Preclinical and Discovery Stage Products
24. Company Name
25. Product Name
26. Drug profiles in the detailed report…..
27. Inactive Products
28. Microbiome Unmet needs
29. Microbiome Market drivers and barriers
30. Appendix
For further information on the Microbiome Report @ Microbiome Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/microbiome-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Polycythemia Market: https://www.delveinsight.com/report-store/polycythemia-vera-market
• Ambulatory Arrhythmia Monitoring Devices Market: https://www.delveinsight.com/report-store/ambulatory-arrhythmia-monitoring-devices-market
• Choroidal Neovascularization Market: https://www.delveinsight.com/report-store/choroidal-neovascularization-market
• Pruritus Market: https://www.delveinsight.com/report-store/pruritus-market
• Cardiopulmonary Bypass Equipment Market: https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market
• Chemotherapy Induced Anemia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-anemia-market
• Chronic Bronchitis Market: https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market
• Clbp Market: https://www.delveinsight.com/report-store/chronic-lower-back-pain-clbp-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Pemphigus Vulgaris Market: https://www.delveinsight.com/infographics/pemphigus-vulgaris-market
• Polycythemia Vera Market: https://www.delveinsight.com/report-store/polycythemia-vera-market
• Advanced Renal Cell Carcinoma Market: https://www.delveinsight.com/report-store/advanced-renal-cell-carcinoma-rcc-market
• Airway Stent Market Market: https://www.delveinsight.com/report-store/airway-stent-market
• Allergic Conjunctivitis Market: https://www.delveinsight.com/report-store/allergic-conjunctivitis-market
• Alopecia Areata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Alport Syndrome Market: https://www.delveinsight.com/report-store/alport-syndrome-market
• Angioedema Market: https://www.delveinsight.com/report-store/angioedema-market
• Bladder Pain Syndrome Market: https://www.delveinsight.com/report-store/interstitial-cystitis-market
• Bone Densitometers Market: https://www.delveinsight.com/report-store/bone-densitometers-market
• Brain Aneurysm Stents Market: https://www.delveinsight.com/report-store/brain-aneurysm-stents-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-market
• Chronic Inflammatory Demyelinating Polyneuropathy Market: https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
• Chronic Inflammtory Demyelinating Polyneuropathy Market: https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myeloid-leukemia-market
• Cutaneous T-cell Lymphoma Market: https://www.delveinsight.com/report-store/cutaneous-t-cell-lymphoma-ctcl-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Dermal Erythema Market: https://www.delveinsight.com/report-store/dermal-erythema-market
• Atopic dermatitis Market: https://www.delveinsight.com/report-store/atopic-dermatitis-market
Contact Info:
Ankit Nigam
Manager (Marketing & Branding)
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Microbiome Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapies, ROA, MOA and Key Companies involved by DelveInsight | Ferring Pharmaceuticals, Miyarisan Pharmaceutical, Seres therapeutics, 4D Pharma, Caelus Health, MRM Health, Scioto Biosc here
News-ID: 3472465 • Views: …
More Releases from DelveInsight Business Research
Primary Biliary Cholangitis Market Expected to Experience Major Growth by 2034, …
DelveInsight's "Primary Biliary Cholangitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Primary Biliary Cholangitis, historical and forecasted epidemiology as well as the Primary Biliary Cholangitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Primary Biliary Cholangitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Primary Biliary Cholangitis…
Advanced Renal Cell Carcinoma Pipeline 2025: Therapies, MOA Insights, and Key Cl …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Advanced Renal Cell Carcinoma Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across…
Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis b …
DelveInsight's "Alport Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Alport Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alport Syndrome Market Forecast
https://www.delveinsight.com/sample-request/alport-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Angioedema Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Angioedema pipeline constitutes 20+ key companies continuously working towards developing 20+ Angioedema treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Angioedema Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
More Releases for Microbiome
Microbiome Sequencing Service Market Expanding Rapidly with Advances in Microbio …
Market Overview
The microbiome sequencing service market is estimated to be valued at USD 2.19 Bn in 2025 and is expected to reach USD 4.64 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.
Coherent Market Insights has released a comprehensive new report offering an in-depth analysis of the Microbiome Sequencing Service Market from 2025 to 2032. This study provides reliable global and regional projections,…
Global Microbiome Market | Global Microbiome Industry | Global Microbiome Market …
The microbiome market comprises of sales of bioactive molecules and linked products which are utilized as immunotherapeutic agents in pharmaceuticals industry. The microbiome market is principally engaged in the improvement and sales of such bioactive products which are utilized as immunotherapy for a wide variability of conditions such as infectious syndromes, endocrine & metabolic disorders, inflammatory conditions, cancer, irritable bowel syndrome, neurological syndromes, hematological disorders and cardiovascular sickness as well.
According…
Global Microbiome Sequencing Services Market to 2022| Metabiomics, Microbiome Th …
Albany, NY, 29th January : Recent research and the current scenario as well as future market potential of "Microbiome Sequencing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022" globally.
Global Microbiome Sequencing Services Market: Overview
The global microbiome sequencing services market is profiled in detail in the report with the help of detailed historical databases, which illustrate the historical growth patterns of the microbiome sequencing…
Improved microbiome sequencing capabilities are likely to boost the global micro …
According to the latest market report published by Persistence Market Research, titled ‘Microbiome Therapeutics Market Potential: Global Pipeline Analysis and Assessment 2018 – 2025’, the global microbiome therapeutics market is expected to exhibit an exponential CAGR of 62.9% during the forecast period 2018–2025.
Request for sample report: https://www.persistencemarketresearch.com/samples/7990
Persistence Market Research estimates that the global market for microbiome therapeutics is expected to be valued at US$ 10.1 Mn in 2018 and is…
Global Microbiome Sequencing Services Market to 2022| Metabiomics, Microbiome Th …
Albany, NY, 1st November : Recent research and the current scenario as well as future market potential of "Microbiome Sequencing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022" globally.
Global Microbiome Sequencing Services Market: Overview
The global microbiome sequencing services market is profiled in detail in the report with the help of detailed historical databases, which illustrate the historical growth patterns of the microbiome sequencing…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
